Background and aim of the work: The incidence of Ulcerative Colitis is rising
globally, but so are the quality of medical care and the range of UC treatment
choices. This study compared the quality of life for UC patients who
underwent surgical treatment versus medical treatment to discover which is
superior and to offer data for clinical use. Methods: A retrospective cohort
study at King Abdulaziz University Hospital in Jeddah, Saudi Arabia was
performed on a total of 352 UC patients who required hospitalization between
January 2010 and October 2022 were classified based on surgical treatment.
The sample size 184 was calculated using 5% margin error, 95% confidence
interval. First class composed of 18 out of 34 surgically treated patients,
second class composed of 166 out of 318 medically treated patients (nonsurgical),
QoL was measured using SF-36. Results: A total of 184 individuals
with UC were included in the study; 90.2% of them were receiving medical
care and 9.8% underwent surgery. Quality of life was significantly higher
among medically treated patients for emotional wellbeing (64.7% � 21.9%).
Additionally, those who received medical treatment had much better overall
health (56.4% 18.3). Additionally, compared to 33.3% of patients receiving
surgical treatment, 44% of those receiving medicinal treatment had an overall
high quality of life (P=.024). Conclusion: In terms of symptoms, flare-ups and
quality of life our study showed that the medical treatment options
considered to improved management of the condition. Asthma, hypertension,
hyperlipidemia and diabetes mellitus were found to be unrelated according to
the study.
Keywords: Ulcerative colitis, Medical treatment, Surgical treatment, King
Abdulaziz University, Saudi Arabia
